What if? <br>You could eliminate pre procedural steps for large bore vascular closure?, <br> You could heal and seal the arteriotomy from the inside?, <br> You could improve vascular complications? What if <br>You could manage Large-Bore vascular closure without any Pre-procedurall steps?, <br> You could heal and seal the arteriotomy from the inside?, <br> You … Home Read More »
Location: Ireland
Employees: 11-50
Total raised: $73.84M
Founded date: 2009
Investors 3
| Date | Name | Website |
| - | Panakes Pa... | panakes.it |
| - | Fountain H... | fh-partner... |
| - | Life Scien... | lspvc.com |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 13.03.2023 | - | $32.02M | - |
| 17.05.2022 | Series D | $23.13M | - |
| 07.10.2016 | - | $380.89K | - |
| 12.09.2016 | Series C | $18.3M | Fountain H... |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | David | Hochman | Board Obse... | linkedin.c... | - | - |
Mentions in press and media 25
| Date | Title | Description |
| 10.07.2026 | Vivasure Medical Submits PMA Application for PerQseal® Elite and Secures Expanded Venous Indication in Europe | Regulatory progress underscores global momentum for PerQseal Elite in transforming large-bore vascular closure Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the su... |
| 10.07.2026 | Vivasure Announces Positive Results of PATCH IDE Pivotal Study Indicating Safety and Efficacy of PerQseal® Large Hole Closure Device | Data from U.S. IDE PATCH Pivotal Study presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 annual conference will support a pre-market approval submission to the FDA Results demonstrate Vivasure’s PerQseal® Closure Device ... |
| 10.07.2026 | Haemonetics Acquires Vivasure Medical Limited | Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced the acquisition of Vivasure Medical Limited (Vivasure), a Galway, Irel... |
| 10.07.2026 | Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System | First fully absorbable, sutureless closure system designed for large-bore procedures aims to improve procedural efficiency and patient outcomes in structural heart interventions Vivasure Medical®, a company pioneering novel fully absorbable... |
| 12.01.2026 | Nodu Raises $1.45M in Pre-Seed Funding | Nodu, a London, UK-based stablecoin infrastructure startup, raised $1.45M in pre-seed funding. The round was led by Digital Space Ventures (an early investor in Revolut and Paysend). The company intends to use the funds to expand operations... |
| 12.01.2026 | SYS Financial to acquire Portlaoise financial planner GTL Life and Pensions | SYS Financial has announced the acquisition of financial planning practice GTL Life and Pensions. The deal forms part of SYS Financial's expansion strategy and will bring its assets under management to €680m overall. The firm has further ac... |
| 12.01.2026 | EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics | EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics Mon, Jan 12, 2026 07:30 CET Report this content EQT Life Sciences to exit portfolio company Vivasure Medical in sale to Haemonetics Vivasure’s PerQseal® Elite system uses a ... |
| 09.01.2026 | Galways's Vivasure Medical acquired for up to €185m | Vivasure Medical, the Galway-based medical device company, has been acquired by the NYSE-listed Haemonetics Corporation in a deal worth up to €185m if certain conditions are met. Vivasure develops advanced polymer implants and delivery syst... |
| 16.04.2024 | Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System | Investigational technology designed for patients undergoing emerging large bore percutaneous catheter-based venous interventional procedures Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel c... |
| 14.11.2023 | Vivasure Medical Announces 100th Patient Enrolled in U.S. Pivotal Study | PATCH Clinical Study will evaluate the safety and efficacy of Vivasure’s PerQseal Closure Device System for large-bore vessel punctures Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel clo... |
Show more